sibutramine
Test Ligands Values Explained
- Test Ligand ID - A unique identifier for the test ligand
- Ligand Name - Name of the test ligand
Test Ligand ID | 5207 |
---|---|
Ligand Name | sibutramine |
PubMed Compound Id | 5210 |
Structure | |
Molecular Formula | C17H26ClN |
Molecular Weight | 279.8 |
SMILES | CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C |
Synonyms | sibutramine 106650-56-0 Medaria Sibutraminum [Latin] Sibutramina [Spanish] Butramin Sibutramina (+/-)-Sibutramine racemic sibutramine 1-[1-(4-chlorophenyl)cyclobutyl]-N,N,3-trimethylbutan-1-amine Cf-alli Sibutramine (INN) CHEBI:9137 Sibutraminum WV5EC51866 SIBUTRAMINE [INN] Sibutramine [INN:BAN] Butramin (TN) SMR000238156 UNII-WV5EC51866 S-Sibutramine DEA No. 1675 BTS 54 524 Spectrum_001961 SIBUTRAMINE [MI] 1-[1-(4-chlorophenyl)cyclobutyl]-N,N,3-trimethyl-butan-1-amine Spectrum2_001686 Spectrum3_001009 Spectrum4_001137 Spectrum5_001440 SIBUTRAMINE [VANDF] SCHEMBL2955 CHEMBL1419 BSPBio_002737 KBioGR_001653 KBioSS_002516 SIBUTRAMINE [WHO-DD] MLS001066619 MLS001401362 SPBio_001612 GTPL2586 DTXSID1023578 BDBM84742 KBio2_002508 KBio2_005076 KBio2_007644 KBio3_001957 HMS2052P05 HMS2090N17 HMS2272C06 HMS3394P05 BCP08127 GEA65056 NSC_5210 BBL010956 STK802066 1-(4-Chlorophenyl)-N,N-dimethyl-alpha-(2-methylpropyl)cyclobutanemethanamine AKOS004119970 AKOS022060500 CCG-101166 DB01105 NC00416 Cyclobutanemethanamine, 1-(4-chlorophenyl)-N,N-dimethyl-alpha-(2-methylpropyl)- NCGC00092357-02 NCGC00092357-04 AC-15773 SBI-0206737.P001 CAS_106650-56-0 NS00005033 C07247 D08513 AB00949538-11 AB00949538_12 Q424151 BRD-A23359898-003-10-0 BRD-A23359898-003-11-8 {1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}dimethylamine (+/-)-1-(P-CHLOROPHENYL)-.ALPHA.-ISOBUTYL-N,N-DIMETHYLCYCLOBUTANEMETHYLAMINE (.+/-.)-1-(p-Chlorophenyl)-.alpha.-isobutyl-N,N-dimethylcyclobutanemethylamine 1-(4-CHLOROPHENYL)-N,N-DIMETHYL-.ALPHA.-(2-METHYLPROPYL)CYCLOBUTANEMETHANAMINE CYCLOBUTANEMETHANAMINE, 1-(4-CHLOROPHENYL)-N,N-DIMETHYL-.ALPHA.-(2-METHYLPROPYL)- |
Created At | Jan 13, 2025 2:47 pm |
Updated At | Jan 13, 2025 2:47 pm |